Ken Griffin Pulmonx Corp Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pulmonx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 69,272 shares of LUNG stock, worth $110,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,272

Previous 2,600 2564.31%

Holding current value

$110,142

Previous $17,000 952.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.57 - $6.87 $293,838 - $785,474	-114,334 Reduced 62.27%	69,272 $179,000
Q1 2025 May 15, 2025	BUY	$5.68 - $9.22 $466,629 - $757,450	82,153 Added 80.98%	183,606 $1.24 Million
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.71 $587,983 - $764,477	99,154 Added 4312.92%	101,453 $688,000
Q3 2024 Nov 14, 2024	SELL	$5.59 - $8.58 $826,822 - $1.27 Million	-147,911 Reduced 98.47%	2,299 $19,000
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $97,784 - $166,419	16,947 Added 12.72%	150,210 $952,000
Q1 2024 May 15, 2024	BUY	$8.71 - $14.65 $682,271 - $1.15 Million	78,332 Added 142.6%	133,263 $1.24 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $13.14 $405,364 - $675,093	51,377 Added 1445.61%	54,931 $700,000
Q3 2023 Nov 14, 2023	SELL	$9.88 - $14.0 $63,745 - $90,328	-6,452 Reduced 64.48%	3,554 $36,000
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $1.66 Million - $2.1 Million	-153,623 Reduced 93.88%	10,006 $131,000
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $695,146 - $1.16 Million	92,810 Added 131.05%	163,629 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$4.92 - $17.35 $351,578 - $1.24 Million	-71,459 Reduced 50.22%	70,819 $597,000
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $1.86 Million - $2.91 Million	-121,193 Reduced 46.0%	142,278 $2.37 Million
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $1.2 Million - $2.39 Million	85,518 Added 48.06%	263,471 $3.88 Million
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $1.74 Million - $2.94 Million	82,432 Added 86.3%	177,953 $4.42 Million
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $10.4 Million - $15.8 Million	-350,290 Reduced 78.57%	95,521 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $6.41 Million - $7.93 Million	178,267 Added 66.63%	445,811 $16 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $3.37 Million - $4.3 Million	89,558 Added 50.32%	267,544 $11.8 Million
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $2.12 Million - $3.26 Million	48,241 Added 37.18%	177,986 $8.14 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $5.1 Million - $8.95 Million	129,745 New	129,745 $8.96 Million

Others Institutions Holding LUNG

# of Institutions

121

Shares Held

33.9M

Call Options Held

Put Options Held

12K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $59.3M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account